Open AccessThree cases of nonmetastatic prostate cancer treated successfully with primary intermittent androgen deprivation therapy over 10 years
Author(s) -
Shida Yohei,
Hakariya Tomoaki,
Miyata Yasuyoshi,
Sakai Hideki
Publication year - 2017
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.854
Subject(s) - medicine , prostate cancer , androgen deprivation therapy , hormone therapy , prostatectomy , cancer , oncology , asymptomatic , flutamide , prostate specific antigen , population , prostate , gynecology , urology , androgen receptor , breast cancer , environmental health
Key Clinical Message We report three cases of nonmetastatic prostate cancer treated effectively with long‐term primary intermittent androgen deprivation (IAD). IAD is not a standard therapy for patients with nonmetastatic prostate cancer. However, based on our experience, we suggest that IAD is one of useful therapeutic tools under certain patients’ condition.